Literature DB >> 18422337

Subattomole sensitivity in biological accelerator mass spectrometry.

Mehran Salehpour1, Göran Possnert, Helge Bryhni.   

Abstract

The Uppsala University 5 MV Pelletron tandem accelerator has been used to study (14)C-labeled biological samples utilizing accelerator mass spectrometry (AMS) technology. We have adapted a sample preparation method for small biological samples down to a few tens of micrograms of carbon, involving among others, miniaturizing of the graphitization reactor. Standard AMS requires about 1 mg of carbon with a limit of quantitation of about 10 amol. Results are presented for a range of small sample sizes with concentrations down to below 1 pM of a pharmaceutical substance in human blood. It is shown that (14)C-labeled molecular markers can be routinely measured from the femtomole range down to a few hundred zeptomole (10 (-21) mol), without the use of any additional separation methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422337     DOI: 10.1021/ac800174j

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  14 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Carbon isotopes profiles of human whole blood, plasma, red blood cells, urine and feces for biological/biomedical 14C-accelerator mass spectrometry applications.

Authors:  Seung-Hyun Kim; Jennifer C Chuang; Peter B Kelly; Andrew J Clifford
Journal:  Anal Chem       Date:  2011-03-31       Impact factor: 6.986

Review 3.  Ethics of drug research in the pediatric intensive care unit.

Authors:  Niina Kleiber; Krista Tromp; Miriam G Mooij; Suzanne van de Vathorst; Dick Tibboel; Saskia N de Wildt
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

4.  Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP.

Authors:  Monica L Vermillion Maier; Lisbeth K Siddens; Jamie M Pennington; Sandra L Uesugi; Kim A Anderson; Lane G Tidwell; Susan C Tilton; Ted J Ognibene; Kenneth W Turteltaub; Jordan N Smith; David E Williams
Journal:  Environ Int       Date:  2021-12-15       Impact factor: 9.621

5.  Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.

Authors:  Seung-Hyun Kim; Peter B Kelly; Volkan Ortalan; Nigel D Browning; Andrew J Clifford
Journal:  Anal Chem       Date:  2010-03-15       Impact factor: 6.986

6.  Calculating radiation exposures during use of (14)C-labeled nutrients, food components, and biopharmaceuticals to quantify metabolic behavior in humans.

Authors:  Seung-Hyun Kim; Peter B Kelly; Andrew J Clifford
Journal:  J Agric Food Chem       Date:  2010-04-28       Impact factor: 5.279

Review 7.  Microdosing and drug development: past, present and future.

Authors:  Graham Lappin; Robert Noveck; Tal Burt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-04-04       Impact factor: 4.481

8.  A microdose study of ¹⁴C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung.

Authors:  G Lappin; M J Boyce; T Matzow; S Lociuro; M Seymour; S J Warrington
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

9.  Carotid plaque age is a feature of plaque stability inversely related to levels of plasma insulin.

Authors:  Sara Hägg; Mehran Salehpour; Peri Noori; Jesper Lundström; Göran Possnert; Rabbe Takolander; Peter Konrad; Stefan Rosfors; Arno Ruusalepp; Josefin Skogsberg; Jesper Tegnér; Johan Björkegren
Journal:  PLoS One       Date:  2011-04-07       Impact factor: 3.240

10.  Accelerator mass spectrometry targets of submilligram carbonaceous samples using the high-throughput Zn reduction method.

Authors:  Seung-Hyun Kim; Peter B Kelly; Andrew J Clifford
Journal:  Anal Chem       Date:  2009-07-15       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.